The evolving landscape for compounded GLP-1 drugs
- Mark Ziats
- Dec 24, 2024
- 1 min read
Updated: Mar 2
A lawsuit from a compounding trade group in October claimed tirzepatide was still in shortage, forcing the FDA to reassess.
FDA says tirzepatide shortage is over after taking a second look
Comments